LSV Asset Management cut its position in shares of Express Scripts Holding Co. (NASDAQ:ESRX) by 2.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,403,479 shares of the company’s stock after selling 87,827 shares during the period. LSV Asset Management owned about 0.54% of Express Scripts Holding worth $257,983,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Kelman Lazarov Inc. acquired a new position in shares of Express Scripts Holding during the first quarter worth $3,603,000. Gibraltar Capital Management Inc. raised its position in shares of Express Scripts Holding by 14.2% in the first quarter. Gibraltar Capital Management Inc. now owns 50,788 shares of the company’s stock worth $3,489,000 after buying an additional 6,305 shares in the last quarter. Rhenman & Partners Asset Management AB raised its position in shares of Express Scripts Holding by 43.2% in the first quarter. Rhenman & Partners Asset Management AB now owns 106,000 shares of the company’s stock worth $7,281,000 after buying an additional 32,000 shares in the last quarter. Fox Run Management L.L.C. acquired a new position in shares of Express Scripts Holding during the first quarter worth $364,000. Finally, Country Trust Bank raised its position in shares of Express Scripts Holding by 9.8% in the first quarter. Country Trust Bank now owns 462,246 shares of the company’s stock worth $31,752,000 after buying an additional 41,186 shares in the last quarter. 88.52% of the stock is currently owned by institutional investors and hedge funds.

Express Scripts Holding Co. (NASDAQ:ESRX) traded up 1.92% during trading on Thursday, hitting $70.99. The stock had a trading volume of 2,854,792 shares. The firm has a market cap of $44.74 billion, a price-to-earnings ratio of 17.54 and a beta of 1.31. The firm’s 50 day moving average is $73.76 and its 200 day moving average is $73.65. Express Scripts Holding Co. has a 1-year low of $65.55 and a 1-year high of $89.20.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Monday, July 25th. The company reported $1.57 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.57. Express Scripts Holding had a return on equity of 23.98% and a net margin of 2.64%. The business had revenue of $25.20 billion for the quarter, compared to the consensus estimate of $25.42 billion. During the same quarter in the previous year, the company posted $1.44 earnings per share. Express Scripts Holding’s revenue for the quarter was down .9% compared to the same quarter last year. On average, analysts anticipate that Express Scripts Holding Co. will post $6.37 earnings per share for the current year.

A number of research analysts recently weighed in on the company. Sanford C. Bernstein reaffirmed an “underperform” rating and set a $68.00 price objective on shares of Express Scripts Holding in a report on Tuesday, September 6th. Leerink Swann reaffirmed a “market perform” rating and set a $80.00 price objective on shares of Express Scripts Holding in a report on Thursday, September 1st. Jefferies Group reaffirmed a “buy” rating and set a $88.00 price objective on shares of Express Scripts Holding in a report on Monday, August 29th. Zacks Investment Research lowered Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Finally, Mizuho upped their price objective on Express Scripts Holding from $77.00 to $82.00 and gave the stock a “neutral” rating in a report on Tuesday, August 2nd. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $82.05.

In related news, Director Woodrow A. Myers, Jr. sold 12,036 shares of Express Scripts Holding stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $70.40, for a total transaction of $847,334.40. Following the completion of the sale, the director now owns 14,918 shares of the company’s stock, valued at $1,050,227.20. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Christopher A. Mcginnis sold 1,785 shares of Express Scripts Holding stock in a transaction on Monday, September 12th. The shares were sold at an average price of $70.77, for a total value of $126,324.45. Following the sale, the vice president now directly owns 4,955 shares of the company’s stock, valued at approximately $350,665.35. The disclosure for this sale can be found here. Insiders own 0.54% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

5 Day Chart for NASDAQ:ESRX

Receive News & Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related companies with MarketBeat.com's FREE daily email newsletter.